Certain Blood Flow Restriction Devices With Rotatable Windlasses and Components Thereof; Notice of Issuance of a General Exclusion Order, a Limited Exclusion Order, and Cease and Desist Orders; Termination of the Investigation, 80930-80931 [2024-22937]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
80930
Federal Register / Vol. 89, No. 193 / Friday, October 4, 2024 / Notices
submit to the Commission on or before
5:15 p.m. on October 24, 2024, a written
brief containing information and
arguments pertinent to the subject
matter of the investigations. Parties shall
file written testimony and
supplementary material in connection
with their presentation at the conference
no later than noon on October 18, 2024.
All written submissions must conform
with the provisions of § 201.8 of the
Commission’s rules; any submissions
that contain BPI must also conform with
the requirements of §§ 201.6, 207.3, and
207.7 of the Commission’s rules. The
Commission’s Handbook on Filing
Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf, elaborates
upon the Commission’s procedures with
respect to filings.
In accordance with §§ 201.16(c) and
207.3 of the rules, each document filed
by a party to the investigations must be
served on all other parties to the
investigations (as identified by either
the public or BPI service list), and a
certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Certification.—Pursuant to § 207.3 of
the Commission’s rules, any person
submitting information to the
Commission in connection with these
investigations must certify that the
information is accurate and complete to
the best of the submitter’s knowledge. In
making the certification, the submitter
will acknowledge that any information
that it submits to the Commission
during these investigations may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of these or related investigations or
reviews, or (b) in internal investigations,
audits, reviews, and evaluations relating
to the programs, personnel, and
operations of the Commission including
under 5 U.S.C. Appendix 3; or (ii) by
U.S. government employees and
contract personnel, solely for
cybersecurity purposes. All contract
personnel will sign appropriate
nondisclosure agreements.
Authority: These investigations are
being conducted under authority of title
VII of the Tariff Act of 1930; this notice
is published pursuant to § 207.12 of the
Commission’s rules.
By order of the Commission.
VerDate Sep<11>2014
17:26 Oct 03, 2024
Jkt 265001
Issued: September 30, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–22956 Filed 10–3–24; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1364]
Certain Blood Flow Restriction Devices
With Rotatable Windlasses and
Components Thereof; Notice of
Issuance of a General Exclusion Order,
a Limited Exclusion Order, and Cease
and Desist Orders; Termination of the
Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission (‘‘Commission’’) has
determined to issue a general exclusion
order (‘‘GEO’’) prohibiting the
importation of blood flow restriction
devices with rotatable windlasses and
components thereof that infringe one or
more of claims 1, 4, 15, or 16 of U.S.
Patent No. 7,842,067 (‘‘the ’067 patent’’);
a limited exclusion order (‘‘LEO’’)
prohibiting the unlicensed entry of
blood flow restriction devices with
rotatable windlasses and components
thereof that infringe the asserted
trademarks and trade dress that are
manufactured by or on behalf of, or
imported by or on behalf of defaulting
respondents; and cease and desist
orders (‘‘CDOs’’) directed against certain
defaulting respondents. The
investigation is terminated.
FOR FURTHER INFORMATION CONTACT:
Joelle P. Justus, Esq., Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
205–2593. Copies of non-confidential
documents filed in connection with this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on May 31, 2023, based on a complaint,
SUMMARY:
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
as supplemented, filed by Composite
Resources, Inc. of Rock Hill, South
Carolina, and North American Rescue,
LLC of Greer, South Carolina
(collectively, ‘‘Complainants’’). 88 FR
34893–95 (May 31, 2023). The
complaint, as supplemented, alleged
violations of section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C.
1337, in the importation into the United
States, sale for importation, or sale in
the United States after importation of
certain blood flow restriction devices
with rotatable windlasses and
components thereof that infringe one or
more of: claims 1–17 of the ’067 patent,
claims 1–30 of the U.S. Patent No.
8,888,807 (‘‘the ’807 patent’’), and
claims 1–13 of the U.S. Patent No.
10,016,203 (‘‘the ’203 patent’’); United
States Trademark Registration Nos.
3,863,064 and 5,064,378; and trade
dress infringement in violation of
Section 43(a) of the Lanham Act (15
U.S.C. 1125) the threat or effect of
which is to destroy or substantially
injure an industry in the United States.
Id. at 34893–94; see Complaint, ¶¶ 9–15.
The complaint also requested the
issuance of a GEO with respect to all of
these allegations.
The Commission’s notice of
investigation named the following
respondents: (1) Anping Longji Medical
Equipment Factory of Hengshui City,
China; Dongguanwin Si Hai Precision
Mold Co., Ltd. of Dongguan, China;
Eiffel Medical Supplies Co., Ltd. of
Shenzhen, China; Empire State
Distributors Inc. of Brooklyn, New York;
EMRN Medical Equipment of LaSalle,
Canada; GD Tianwu New Material Tech
Co., Ltd. of Shawan Town, China;
Hengshui Runde Medical Instruments
Co., Ltd. of Hengshui City, China;
Putian Dima Trading Co., Ltd. of Putian
City, China; Rhino Inc. of Lewes,
Delaware; Shanghai Sixu International
Freight Agent Co., Ltd. of Shanghai,
China; Shenzhen Anben E-Commerce
Co., Ltd. of Shenzhen, China; Shenzhen
TMI Medical Supplies Co., Ltd. of
Shenzhen, China; Shenzhen Yujie
Commercial and Trading Co., Ltd. of
Shenzhen, China; Wuxi Emsrun
Technology Co., Ltd. of Wuxi City,
China; Wuxi Golden Hour Medical
Technology Co., Ltd. of Wuxi City,
China; and Wuxi Puneda Technology
Co., Ltd. of Wuxi City, China
(collectively, ‘‘the Defaulting
Respondents’’); (2) Chaozhou Jiduo
Trading Co., Ltd. of Chaozhou City,
China; Dongguan Hongsui Electronic
Commerce, Co., Ltd. of Dongguan City,
China; Fuzhou Meirun Medical
Equipment Technology Co., Ltd. of
Fuzhou, China; Henan Eyocean E-
E:\FR\FM\04OCN1.SGM
04OCN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 193 / Friday, October 4, 2024 / Notices
Commerce Co., Ltd. of Zhengzhou,
China; Huang Xia of Sangzi Town,
China; Jingcai Jiang of Shenzhen, China;
Shen Yi of Shenzhen, China; Shenzhen
Janxle E E Commerce Co., Ltd. of
Shenzhen, China; Shenzhen Smart
Medical Co. Ltd. of Shenzhen, China;
Sun Minghui of Shenzhen, China; Xia
Guo Long of Dongguan City, China; and
Yinping Yin of Shenzhen, China
(collectively, ‘‘the Unserved
Respondents’’); and (3) Express
Companies, Inc. of Oceanside,
California, and SZY Holdings LLC of
Brooklyn, New York (collectively, ‘‘the
Participating Respondents’’). Id. The
Office of Unfair Import Investigations
(‘‘OUII’’) is also a party to this
investigation.
The Commission terminated the
Participating Respondents based on the
entry of consent orders. See Order No.
7 (Aug. 9, 2023), unreviewed by Comm’n
Notice (Sept. 5, 2023); Order No. 13
(Oct. 3, 2023), unreviewed by Comm’n
Notice (Nov. 2, 2023). The Commission
also terminated the Unserved
Respondents based on the withdrawal of
the complaint as to those respondents.
See Order No. 10 (Aug. 22, 2023),
unreviewed by Comm’n Notice (Sept.
20, 2023). The Commission also found
the Defaulting Respondents in default.
See Order No. 11 (Aug. 29, 2023),
unreviewed by Comm’n Notice (Sept.
22, 2023).
On November 1, 2023, Complainants
filed a motion to partially terminate the
investigation with respect to the ’807
and ’203 patents. On November 2, 2023,
the ALJ issued Order No. 14 granting the
motion. Order No. 14 (Nov. 2, 2023),
unreviewed by Comm’n Notice (Dec. 4,
2023). On January 23, 2024,
Complainants filed a motion to
terminate claims 2, 3, 5–14, and 17 of
the ’067 patent. On January 25, 2024,
the ALJ issued Order No. 19 granting the
motion. Order No. 19 (Jan. 25, 2024),
unreviewed by Comm’n Notice (Feb. 15,
2024). Therefore, only claims 1, 4, 15,
and 16 of the ’067 patent remained
asserted.
On December 22, 2023, Complainants
filed a motion for summary
determination on violation of section
337 with regard to the ’067 patent,
asserted trademarks, and asserted trade
dress by the Defaulting Respondents. On
February 7, 2024, the ALJ issued Order
No. 20, granting the motion in part with
respect to the claims 1, 4, 15, and 16 of
the ’067 patent. Order No. 20 (Feb. 7,
2024), unreviewed by Comm’n Notice
(Mar. 6, 2024). Order No. 20 found that
(1) the importation requirement was
satisfied with respect to the Defaulting
Respondents with the exception of
Empire State Distributors Inc.; (2) the
VerDate Sep<11>2014
17:26 Oct 03, 2024
Jkt 265001
accused products infringe claims 1, 4,
15, and 16 of the ’067 patent; (3) the
domestic industry products practice
claim 1 of the ’067 patent; and (4) the
economic prong of the domestic
industry was satisfied. Id. The
Commission determined not to review
the affirmative findings in Order No. 20.
See Comm’n Notice (Mar. 6, 2024).
On March 1, 2024, Complainants filed
a motion to terminate the investigation
in part based on a withdrawal of its
request for a GEO as to the trademark
and trade dress claims and to cancel the
evidentiary hearing. On March 19, 2024,
the ALJ granted the motion and issued
Order No. 23, which was styled as an
initial determination. The Commission
determined that the request to withdraw
a requested remedy is not properly the
subject of a motion for termination nor
an issue that must be decided in the
form of an initial determination.
Comm’n Notice at 3 (April 18, 2024).
Accordingly, the Commission treated
Order No. 23 as an order and not an
initial determination. Id.
Order No. 23 also included the ALJ’s
Recommended Determination (‘‘RD’’) on
remedy and bonding. Specifically, the
RD recommended that the Commission
issue a GEO as to claims 1, 4, 15, and
16 of the ’067 patent. RD at 9–12. The
RD further recommended issuing an
LEO as well as CDOs against each of the
Defaulting Respondents in connection
with the patent, trademark, and trade
dress claims. Id. at 13–15. Finally, the
RD recommended that the Commission
set the bond during the Presidential
review period at one hundred percent
(100%). Id. at 15–16.
The Commission issued a notice
soliciting comments regarding any
public interest concerns raised by the
recommend relief appeared in the
Federal Register on April 2, 2024. See
89 FR 22741 (Apr. 2, 2024).
Complainants filed a statement on
public interest pursuant to Commission
Rule 210.50(a)(4), 19 CFR 210.50(a)(4),
but no other comments were received in
response to the notice.
The Commission requested briefing
on remedy, bonding, and the public
interest. Comm’n Notice (Apr. 18, 2024);
89 FR 31214–6 (Apr. 24, 2024). On May
2, 2024, Complainants and OUII filed
opening submissions. On May 16, 2024,
Complainants and OUII filed responsive
submissions. No other party filed a
submission before the Commission.
Having reviewed the record of the
investigation, including the RD and the
parties’ submissions, the Commission
has determined that the appropriate
remedy is: (1) a GEO prohibiting the
unlicensed entry of blood flow
restriction devices with rotatable
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
80931
windlasses and components thereof that
infringe one or more of claims 1, 4, 15,
and/or 16 of the ’067 patent; (2) an LEO
prohibiting the unlicensed entry of
blood flow restriction devices with
rotatable windlasses and components
thereof that infringe the asserted
trademarks and/or the asserted trade
dress manufactured by or on behalf of,
or imported by or on behalf of any of the
Defaulting Respondents; and (3) CDOs
directed against Anping Longji Medical
Equipment Factory; Empire State
Distributors Inc.; Hengshui Runde
Medical Instruments Co., Ltd.; Putian
Dima Trading Co., Ltd.; Rhino Inc.;
Shenzhen Anben E-Commerce Co., Ltd.;
Shenzhen Yujie Commercial and
Trading Co., Ltd.; Wuxi Emsrun
Technology Co., Ltd.; and Wuxi Puneda
Technology Co., Ltd.
The Commission has further
determined that the public interest
factors enumerated in subsections (d)(l),
(f)(1), and (g)(1) (19 U.S.C. 1337(d)(l),
(f)(1), (g)(1)) do not preclude issuance of
the above referenced remedial orders.
Additionally, the Commission has
determined to impose a bond of 100%
of entered value of the covered products
during the period of Presidential review
(19 U.S.C. 1337(j)).
This investigation is terminated.
The Commission vote for this
determination took place on September
30, 2024.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and in part 210 of the Commission’s
Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: September 30, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–22937 Filed 10–3–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB 1140–0031]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision of a
Previously Approved Collection;
Records of Acquisition and
Disposition by Registered Importers of
Arms, Ammunition, and Defense
Articles on the U.S. Munitions Import
List
Bureau of Alcohol, Tobacco,
Firearms, and Explosives, Department of
Justice.
ACTION: 60-Day notice.
AGENCY:
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 89, Number 193 (Friday, October 4, 2024)]
[Notices]
[Pages 80930-80931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22937]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1364]
Certain Blood Flow Restriction Devices With Rotatable Windlasses
and Components Thereof; Notice of Issuance of a General Exclusion
Order, a Limited Exclusion Order, and Cease and Desist Orders;
Termination of the Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission (``Commission'') has determined to issue a general exclusion
order (``GEO'') prohibiting the importation of blood flow restriction
devices with rotatable windlasses and components thereof that infringe
one or more of claims 1, 4, 15, or 16 of U.S. Patent No. 7,842,067
(``the '067 patent''); a limited exclusion order (``LEO'') prohibiting
the unlicensed entry of blood flow restriction devices with rotatable
windlasses and components thereof that infringe the asserted trademarks
and trade dress that are manufactured by or on behalf of, or imported
by or on behalf of defaulting respondents; and cease and desist orders
(``CDOs'') directed against certain defaulting respondents. The
investigation is terminated.
FOR FURTHER INFORMATION CONTACT: Joelle P. Justus, Esq., Office of the
General Counsel, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 205-2593. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. General information concerning the Commission may
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on
this matter can be obtained by contacting the Commission's TDD terminal
on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on May 31, 2023, based on a complaint, as supplemented, filed by
Composite Resources, Inc. of Rock Hill, South Carolina, and North
American Rescue, LLC of Greer, South Carolina (collectively,
``Complainants''). 88 FR 34893-95 (May 31, 2023). The complaint, as
supplemented, alleged violations of section 337 of the Tariff Act of
1930, as amended, 19 U.S.C. 1337, in the importation into the United
States, sale for importation, or sale in the United States after
importation of certain blood flow restriction devices with rotatable
windlasses and components thereof that infringe one or more of: claims
1-17 of the '067 patent, claims 1-30 of the U.S. Patent No. 8,888,807
(``the '807 patent''), and claims 1-13 of the U.S. Patent No.
10,016,203 (``the '203 patent''); United States Trademark Registration
Nos. 3,863,064 and 5,064,378; and trade dress infringement in violation
of Section 43(a) of the Lanham Act (15 U.S.C. 1125) the threat or
effect of which is to destroy or substantially injure an industry in
the United States. Id. at 34893-94; see Complaint, ]] 9-15. The
complaint also requested the issuance of a GEO with respect to all of
these allegations.
The Commission's notice of investigation named the following
respondents: (1) Anping Longji Medical Equipment Factory of Hengshui
City, China; Dongguanwin Si Hai Precision Mold Co., Ltd. of Dongguan,
China; Eiffel Medical Supplies Co., Ltd. of Shenzhen, China; Empire
State Distributors Inc. of Brooklyn, New York; EMRN Medical Equipment
of LaSalle, Canada; GD Tianwu New Material Tech Co., Ltd. of Shawan
Town, China; Hengshui Runde Medical Instruments Co., Ltd. of Hengshui
City, China; Putian Dima Trading Co., Ltd. of Putian City, China; Rhino
Inc. of Lewes, Delaware; Shanghai Sixu International Freight Agent Co.,
Ltd. of Shanghai, China; Shenzhen Anben E-Commerce Co., Ltd. of
Shenzhen, China; Shenzhen TMI Medical Supplies Co., Ltd. of Shenzhen,
China; Shenzhen Yujie Commercial and Trading Co., Ltd. of Shenzhen,
China; Wuxi Emsrun Technology Co., Ltd. of Wuxi City, China; Wuxi
Golden Hour Medical Technology Co., Ltd. of Wuxi City, China; and Wuxi
Puneda Technology Co., Ltd. of Wuxi City, China (collectively, ``the
Defaulting Respondents''); (2) Chaozhou Jiduo Trading Co., Ltd. of
Chaozhou City, China; Dongguan Hongsui Electronic Commerce, Co., Ltd.
of Dongguan City, China; Fuzhou Meirun Medical Equipment Technology
Co., Ltd. of Fuzhou, China; Henan Eyocean E-
[[Page 80931]]
Commerce Co., Ltd. of Zhengzhou, China; Huang Xia of Sangzi Town,
China; Jingcai Jiang of Shenzhen, China; Shen Yi of Shenzhen, China;
Shenzhen Janxle E E Commerce Co., Ltd. of Shenzhen, China; Shenzhen
Smart Medical Co. Ltd. of Shenzhen, China; Sun Minghui of Shenzhen,
China; Xia Guo Long of Dongguan City, China; and Yinping Yin of
Shenzhen, China (collectively, ``the Unserved Respondents''); and (3)
Express Companies, Inc. of Oceanside, California, and SZY Holdings LLC
of Brooklyn, New York (collectively, ``the Participating
Respondents''). Id. The Office of Unfair Import Investigations
(``OUII'') is also a party to this investigation.
The Commission terminated the Participating Respondents based on
the entry of consent orders. See Order No. 7 (Aug. 9, 2023), unreviewed
by Comm'n Notice (Sept. 5, 2023); Order No. 13 (Oct. 3, 2023),
unreviewed by Comm'n Notice (Nov. 2, 2023). The Commission also
terminated the Unserved Respondents based on the withdrawal of the
complaint as to those respondents. See Order No. 10 (Aug. 22, 2023),
unreviewed by Comm'n Notice (Sept. 20, 2023). The Commission also found
the Defaulting Respondents in default. See Order No. 11 (Aug. 29,
2023), unreviewed by Comm'n Notice (Sept. 22, 2023).
On November 1, 2023, Complainants filed a motion to partially
terminate the investigation with respect to the '807 and '203 patents.
On November 2, 2023, the ALJ issued Order No. 14 granting the motion.
Order No. 14 (Nov. 2, 2023), unreviewed by Comm'n Notice (Dec. 4,
2023). On January 23, 2024, Complainants filed a motion to terminate
claims 2, 3, 5-14, and 17 of the '067 patent. On January 25, 2024, the
ALJ issued Order No. 19 granting the motion. Order No. 19 (Jan. 25,
2024), unreviewed by Comm'n Notice (Feb. 15, 2024). Therefore, only
claims 1, 4, 15, and 16 of the '067 patent remained asserted.
On December 22, 2023, Complainants filed a motion for summary
determination on violation of section 337 with regard to the '067
patent, asserted trademarks, and asserted trade dress by the Defaulting
Respondents. On February 7, 2024, the ALJ issued Order No. 20, granting
the motion in part with respect to the claims 1, 4, 15, and 16 of the
'067 patent. Order No. 20 (Feb. 7, 2024), unreviewed by Comm'n Notice
(Mar. 6, 2024). Order No. 20 found that (1) the importation requirement
was satisfied with respect to the Defaulting Respondents with the
exception of Empire State Distributors Inc.; (2) the accused products
infringe claims 1, 4, 15, and 16 of the '067 patent; (3) the domestic
industry products practice claim 1 of the '067 patent; and (4) the
economic prong of the domestic industry was satisfied. Id. The
Commission determined not to review the affirmative findings in Order
No. 20. See Comm'n Notice (Mar. 6, 2024).
On March 1, 2024, Complainants filed a motion to terminate the
investigation in part based on a withdrawal of its request for a GEO as
to the trademark and trade dress claims and to cancel the evidentiary
hearing. On March 19, 2024, the ALJ granted the motion and issued Order
No. 23, which was styled as an initial determination. The Commission
determined that the request to withdraw a requested remedy is not
properly the subject of a motion for termination nor an issue that must
be decided in the form of an initial determination. Comm'n Notice at 3
(April 18, 2024). Accordingly, the Commission treated Order No. 23 as
an order and not an initial determination. Id.
Order No. 23 also included the ALJ's Recommended Determination
(``RD'') on remedy and bonding. Specifically, the RD recommended that
the Commission issue a GEO as to claims 1, 4, 15, and 16 of the '067
patent. RD at 9-12. The RD further recommended issuing an LEO as well
as CDOs against each of the Defaulting Respondents in connection with
the patent, trademark, and trade dress claims. Id. at 13-15. Finally,
the RD recommended that the Commission set the bond during the
Presidential review period at one hundred percent (100%). Id. at 15-16.
The Commission issued a notice soliciting comments regarding any
public interest concerns raised by the recommend relief appeared in the
Federal Register on April 2, 2024. See 89 FR 22741 (Apr. 2, 2024).
Complainants filed a statement on public interest pursuant to
Commission Rule 210.50(a)(4), 19 CFR 210.50(a)(4), but no other
comments were received in response to the notice.
The Commission requested briefing on remedy, bonding, and the
public interest. Comm'n Notice (Apr. 18, 2024); 89 FR 31214-6 (Apr. 24,
2024). On May 2, 2024, Complainants and OUII filed opening submissions.
On May 16, 2024, Complainants and OUII filed responsive submissions. No
other party filed a submission before the Commission.
Having reviewed the record of the investigation, including the RD
and the parties' submissions, the Commission has determined that the
appropriate remedy is: (1) a GEO prohibiting the unlicensed entry of
blood flow restriction devices with rotatable windlasses and components
thereof that infringe one or more of claims 1, 4, 15, and/or 16 of the
'067 patent; (2) an LEO prohibiting the unlicensed entry of blood flow
restriction devices with rotatable windlasses and components thereof
that infringe the asserted trademarks and/or the asserted trade dress
manufactured by or on behalf of, or imported by or on behalf of any of
the Defaulting Respondents; and (3) CDOs directed against Anping Longji
Medical Equipment Factory; Empire State Distributors Inc.; Hengshui
Runde Medical Instruments Co., Ltd.; Putian Dima Trading Co., Ltd.;
Rhino Inc.; Shenzhen Anben E-Commerce Co., Ltd.; Shenzhen Yujie
Commercial and Trading Co., Ltd.; Wuxi Emsrun Technology Co., Ltd.; and
Wuxi Puneda Technology Co., Ltd.
The Commission has further determined that the public interest
factors enumerated in subsections (d)(l), (f)(1), and (g)(1) (19 U.S.C.
1337(d)(l), (f)(1), (g)(1)) do not preclude issuance of the above
referenced remedial orders. Additionally, the Commission has determined
to impose a bond of 100% of entered value of the covered products
during the period of Presidential review (19 U.S.C. 1337(j)).
This investigation is terminated.
The Commission vote for this determination took place on September
30, 2024.
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the
Commission's Rules of Practice and Procedure (19 CFR part 210).
By order of the Commission.
Issued: September 30, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024-22937 Filed 10-3-24; 8:45 am]
BILLING CODE 7020-02-P
